Pascal Pommier
Overview
Explore the profile of Pascal Pommier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyamani N, Clementel E, Sargos P, Blanchard P, Supiot S, Ronchin P, et al.
Radiother Oncol
. 2025 Feb;
206:110780.
PMID: 39924002
Purpose: Radiotherapy quality assurance (RTQA) is essential for ensuring adherence to trial protocols. This paper summarizes the individual case review (ICR) results from the PEACE-1 trial, a phase-III study investigates...
2.
Graff P, Pommier P, Minsat M, Crehange G
Cancer Radiother
. 2024 Oct;
28(6-7):513-518.
PMID: 39384514
Herein, we provide a non-exhaustive selection of the main clinical trials presented in 2023-2024 related to radiation-oncology used in the treatment of urological cancers including prostate cancer (radiotherapy of localized...
3.
Pommier P, Xie W, Ravi P, Carrie C, Dignam J, Feng F, et al.
Radiother Oncol
. 2024 Sep;
201:110532.
PMID: 39278317
Background: Early salvage radiotherapy (SRT) is the standard of care for biochemical recurrence post-prostatectomy but outcomes are heterogeneous. Objective: To develop a risk scoring system based on relevant standard-of-care clinico-pathological...
4.
Buchalet C, Lemanski C, Pommier P, Le Malicot K, Bonichon-Lamichhane N, Evesque L, et al.
Dig Liver Dis
. 2024 Jul;
57(1):97-103.
PMID: 39003165
Introduction: Early-stage anal squamous cell carcinomas (ASCC) are usually treated with chemoradiotherapy (CRT), with good outcomes. Radiotherapy (RT) alone might be sufficient while reducing toxicity. Methods: Patients included in the...
5.
Evin C, Quero L, Le Malicot K, Blanchet-Deverly S, Evesque L, Buchalet C, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(3):708-719.
PMID: 38912999
Purpose: The influence of human immunodeficiency virus (HIV) infection on clinical outcomes in patients receiving (chemo)radiation therapy (RT) for squamous cell carcinoma of the anus (SCCA) is debated. The objective...
6.
Ah-Thiane L, Campion L, Allouache N, Meyer E, Pommier P, Mesgouez-Nebout N, et al.
Eur Urol Oncol
. 2024 May;
8(1):38-46.
PMID: 38734543
Background: The relevance of next-generation hormone therapies and circulating tumor cells (CTCs) are not elucidated in biochemical recurrence after prostatectomy. Objective: To evaluate the combination of abiraterone acetate plus prednisone...
7.
Davila Fajardo R, Scarzello G, Gaze M, Boterberg T, Cameron A, Fuchs J, et al.
Radiother Oncol
. 2024 Apr;
195:110273.
PMID: 38588921
Background And Purpose: The purpose of this study was to address the lack of published data on the use of brachytherapy in pediatric rhabdomyosarcoma by describing current practice as starting...
8.
Vaugier L, Morvan C, Pasquier D, Buthaud X, Magne N, Beckendorf V, et al.
Eur Urol
. 2024 Mar;
87(1):73-76.
PMID: 38490854
Background And Objective: Androgen deprivation therapy (ADT) is a mainstay in metastatic prostate cancer, while additional salvage radiotherapy may offer prolonged remission for patients with regional node relapses. We performed...
9.
Kwak L, Ravi P, Armstrong J, Beckendorf V, Chin J, DAmico A, et al.
J Clin Oncol
. 2024 Mar;
42(18):2132-2138.
PMID: 38471051
Purpose: We sought to evaluate the prognostic impact of prostate-specific antigen (PSA) at 6 months after completion of radiotherapy (RT) in patients treated with RT alone, RT plus short-term (st;...
10.
Perrier L, Balusson F, Morelle M, Castelli J, Thariat J, Benezery K, et al.
Radiother Oncol
. 2024 Feb;
193:110116.
PMID: 38316193
Background And Purpose: We performed a cost-effectiveness analysis (CEA) comparing an adaptive radiotherapy (ART) strategy, based on weekly replanning, aiming to correct the parotid gland overdose during treatment and expecting...